BioCentury
ARTICLE | Clinical News

Travatan Z travoprost regulatory update

November 1, 2010 7:00 AM UTC

FDA approved Travatan Z 0.004% travoprost from Alcon for first-line treatment of elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension. Alcon's Travatan Z is a...